JP2021513337A5 - - Google Patents
Info
- Publication number
- JP2021513337A5 JP2021513337A5 JP2020542604A JP2020542604A JP2021513337A5 JP 2021513337 A5 JP2021513337 A5 JP 2021513337A5 JP 2020542604 A JP2020542604 A JP 2020542604A JP 2020542604 A JP2020542604 A JP 2020542604A JP 2021513337 A5 JP2021513337 A5 JP 2021513337A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- encoded
- nucleic acid
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023223121A JP2024038225A (ja) | 2018-02-11 | 2023-12-28 | Ｃａｒ－ｔ細胞及び自己免疫疾患 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862629103P | 2018-02-11 | 2018-02-11 | |
| US62/629,103 | 2018-02-11 | ||
| PCT/US2019/017532 WO2019157461A1 (en) | 2018-02-11 | 2019-02-11 | Car-t cells and autoimmune diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023223121A Division JP2024038225A (ja) | 2018-02-11 | 2023-12-28 | Ｃａｒ－ｔ細胞及び自己免疫疾患 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021513337A JP2021513337A (ja) | 2021-05-27 |
| JP2021513337A5 true JP2021513337A5 (enExample) | 2022-02-21 |
| JP7475686B2 JP7475686B2 (ja) | 2024-04-30 |
Family
ID=67549696
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020542604A Active JP7475686B2 (ja) | 2018-02-11 | 2019-02-11 | Ｃａｒ－ｔ細胞及び自己免疫疾患 |
| JP2023223121A Withdrawn JP2024038225A (ja) | 2018-02-11 | 2023-12-28 | Ｃａｒ－ｔ細胞及び自己免疫疾患 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023223121A Withdrawn JP2024038225A (ja) | 2018-02-11 | 2023-12-28 | Ｃａｒ－ｔ細胞及び自己免疫疾患 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12421302B2 (enExample) |
| EP (1) | EP3749778A4 (enExample) |
| JP (2) | JP7475686B2 (enExample) |
| KR (1) | KR102795055B1 (enExample) |
| CN (2) | CN118878696A (enExample) |
| AU (2) | AU2019216989B2 (enExample) |
| BR (1) | BR112020016030A2 (enExample) |
| CA (1) | CA3090891A1 (enExample) |
| CL (1) | CL2020002066A1 (enExample) |
| EA (1) | EA202091918A1 (enExample) |
| IL (1) | IL276445A (enExample) |
| MX (1) | MX2020008287A (enExample) |
| SG (1) | SG11202007370RA (enExample) |
| WO (1) | WO2019157461A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201900858D0 (en) * | 2019-01-22 | 2019-03-13 | Price Nicola Kaye | Receptors providing targeted costimulation for adoptive cell therapy |
| JP7439280B2 (ja) | 2020-02-13 | 2024-02-27 | イミュノファーム テクノロジー カンパニー リミテッド | キメラ抗原受容体の最適化 |
| WO2021226589A1 (en) * | 2020-05-08 | 2021-11-11 | The University Of Kansas | Immunomagnetic compositions for the ph-specific capture of extracellular vesicles |
| WO2022094614A1 (en) * | 2020-10-29 | 2022-05-05 | The Regents Of The University Of California | Anti-dpp6 chimeric antigen receptor bearing regulatory t cells |
| WO2023010122A2 (en) * | 2021-07-29 | 2023-02-02 | Sonoma Biotherapeutics, Inc. | Synovial extracellular matrix-specific chimeric antigen receptor for targeting regulatory t cells to treat autoimmune diseases |
| GB202202842D0 (en) * | 2022-03-01 | 2022-04-13 | Belgian Volition Srl | Chimeric antigen receptor T-cell treatments targeted to chromatin fragments and extracellular traps |
| EP4590328A2 (en) * | 2022-09-19 | 2025-07-30 | Sonoma Biotherapeutics, Inc. | Citrullinated antigen-specific chimeric antigen receptors for targeting regulatory t cells to treat hidradenitis suppurativa |
| WO2024254286A2 (en) * | 2023-06-07 | 2024-12-12 | Sonoma Biotherapeutics, Inc. | Methods of detecting citrullinated proteins |
| WO2025090985A1 (en) * | 2023-10-27 | 2025-05-01 | Duke University | Compositions comprising chimeric antigen receptors targeting citrullinated vimentin and methods of use thereof |
| US20260176598A1 (en) | 2024-07-04 | 2026-06-25 | Quell Therapeutics Limited | Expression construct |
| WO2026020171A2 (en) * | 2024-07-19 | 2026-01-22 | Aera Therapeutics, Inc. | Chimeric antigen receptor constructs |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015010791A2 (en) * | 2013-07-24 | 2015-01-29 | Klareskog, Lars | Novel antibodies for the diagnosis and treatment of rheumatoid arthritis |
| CA2936984A1 (en) | 2014-01-24 | 2015-07-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-ny-br-1 polypeptides, proteins, and chimeric antigen receptors |
| DK3186284T3 (da) * | 2014-08-28 | 2022-05-09 | Bioatla Inc | Betinget aktive kimæriske antigenreceptorer til modificerede t-celler |
| ES2909973T3 (es) * | 2015-11-04 | 2022-05-10 | Hope City | Receptores quiméricos para el antígeno que se dirigen a HER2 |
| CN109072194B (zh) * | 2015-12-09 | 2022-12-27 | 纪念斯隆-凯特林癌症中心 | 免疫细胞组合物及其使用方法 |
-
2019
- 2019-02-11 KR KR1020207025997A patent/KR102795055B1/ko active Active
- 2019-02-11 CN CN202410508213.9A patent/CN118878696A/zh active Pending
- 2019-02-11 BR BR112020016030-0A patent/BR112020016030A2/pt not_active Application Discontinuation
- 2019-02-11 US US16/968,794 patent/US12421302B2/en active Active
- 2019-02-11 EP EP19751596.8A patent/EP3749778A4/en active Pending
- 2019-02-11 SG SG11202007370RA patent/SG11202007370RA/en unknown
- 2019-02-11 EA EA202091918A patent/EA202091918A1/ru unknown
- 2019-02-11 CA CA3090891A patent/CA3090891A1/en active Pending
- 2019-02-11 CN CN201980025160.2A patent/CN111954684B/zh active Active
- 2019-02-11 JP JP2020542604A patent/JP7475686B2/ja active Active
- 2019-02-11 MX MX2020008287A patent/MX2020008287A/es unknown
- 2019-02-11 WO PCT/US2019/017532 patent/WO2019157461A1/en not_active Ceased
- 2019-02-11 AU AU2019216989A patent/AU2019216989B2/en active Active
-
2020
- 2020-08-02 IL IL276445A patent/IL276445A/en unknown
- 2020-08-10 CL CL2020002066A patent/CL2020002066A1/es unknown
-
2023
- 2023-12-28 JP JP2023223121A patent/JP2024038225A/ja not_active Withdrawn
-
2025
- 2025-11-26 AU AU2025271320A patent/AU2025271320A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023538891A5 (enExample) | ||
| JP2020108398A5 (enExample) | ||
| RU2755059C2 (ru) | Способы и составы для производства лимфоцитов и их регулируемого увеличения | |
| JP2021532829A5 (enExample) | ||
| JP2019525738A5 (enExample) | ||
| JP2020018311A5 (enExample) | ||
| JP2025023921A (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| JP2020524506A5 (enExample) | ||
| JP2020124210A (ja) | 細胞の集団を拡大する方法、キット、及び装置 | |
| Alonso-Camino et al. | CARbodies: human antibodies against cell surface tumor antigens selected from repertoires displayed on T cell chimeric antigen receptors | |
| JP2024023228A5 (enExample) | ||
| JP2018516554A5 (enExample) | ||
| MX2022010665A (es) | Anticuerpos que se unen al receptor de interleucina 4 (il4r) y usos de los mismos. | |
| JP2019527041A5 (enExample) | ||
| AU2019374790A1 (en) | Process for producing genetically engineered T cells | |
| JP2019514361A5 (enExample) | ||
| JP2012143232A5 (enExample) | ||
| JP2021511041A5 (enExample) | ||
| JP2017511130A5 (enExample) | ||
| JP2018530331A5 (enExample) | ||
| MX2023009022A (es) | Anticuerpos multiespecificos con especificidad para ror1 y cd3. | |
| PH12022552520A1 (en) | Antibodies binding siglec15 and uses thereof | |
| JP2014529590A5 (enExample) | ||
| EP4150057A2 (en) | Process for producing donor-batched cells expressing a recombinant receptor | |
| MY210018A (en) | Monoclonal antibody that binds specifically to gitr |